The consolidated financial results for the quarter ending Dec 31, 2024 (Q3)
Issuance of bonus shares in a 1:20 ratio and and a preferential allotment of 2,63,71,888 equity shares to raise ₹39.55 crore.
Proposal to raise ₹23.78 crore via private placement and to approve IPO
Private Placement of 135950 Shares @1062
New Fund Raise by Lords Mark
Offering 2,20,22,100 equity shares at ₹92 per share on a 1:1 rights basis
The consolidated financial results for the quarter ending Dec 31, 2024 (Q3)
Veeda Clinical Research Files DRHP For Around 1,000 Cr IPO
The consolidated financial results for the quarter ending Dec 31, 2024 (Q3)